MXCT MaxCyte Inc
338
$4.75
$0.12
(2.46%)
| Watchers | 338 |
| 52-Wk Low | $2.45 |
| 52-Wk High | $6.12 |
| Market Cap | $504.42M |
| Volume (M) | 472,132.00 |
| 52-Wk High | $6.12 |
| 52-Wk Low | $2.45 |
MaxCyte (MXCT) Shares Cross Above 200 DMAMarket News Video • 11 days ago
In trading on Monday, shares of MaxCyte Inc (MXCT) crossed above their 200 day moving average of 4.18, changing hands as high as 4.38 per share. MaxCyte Inc shares are currently trading up...
Share to Feed
MaxCyte continues supporting the advancement of novel therapeutics and looks to support education and advancement of mRNA medicinesROCKVILLE, Md., Nov. 16, 2023 (GLOBE NEWSWIRE) -- MaxCyte, Inc...
Allspring Global Investments Holdings LLC lessened its holdings in MaxCyte, Inc. (NASDAQ:MXCT Free Report) by 3.7% in the 2nd quarter, according to the company in its most recent 13F filing...
MaxCyte Reports Third Quarter 2023 Financial Results and Reiterates Full Year 2023 Revenue Guidance ROCKVILLE, MD, November 8, 2023 MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading...
ROCKVILLE, Md., Nov. 08, 2023 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the...
MaxCyte to Participate in Two Upcoming Investor Conferences Rockville, MD, November 6, 2023 MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing...
ROCKVILLE, Md., Nov. 06, 2023 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the...
Dr gerwerk AG Co. KGaA (OTCMKTS:DGWPF Get Free Report) and MaxCyte (NASDAQ:MXCT Get Free Report) are both medical companies, but which is the better stock? We will compare the...
The biotech company reduced full-year guidance and expects so-so third-quarter revenue...
ROCKVILLE, Md., Oct. 04, 2023 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the...